ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,885Medicare Part D Prescriptions Filled, Including Refills

Rank: 163 out of 2604

$505K Total Retail Price of All Prescriptions

Rank: 207 out of 2604

377 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 377 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 377 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 6,229 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 362 169 S3 1 1
LEVOTHYROXINE SODIUM 289 270 2 4
SIMVASTATIN 286 226 3 2
OMEPRAZOLE 268 181 4 5
CARVEDILOL 252 194 5 26
WARFARIN SODIUM 235 209 6 13
FUROSEMIDE 228 210 7 8
LISINOPRIL 203 168 8 3
GABAPENTIN 189 107 9 12
AMLODIPINE BESYLATE 187 152 10 6
SERTRALINE HCL 152 118 11 23
METFORMIN HCL 127 95 12 7
HYDROCHLOROTHIAZIDE 117 83 13 10
ATORVASTATIN CALCIUM 106 85 14 19
MORPHINE SULFATE ER 106 18 S2 14 58
METOPROLOL SUCCINATE 100 75 16 17
DIGOXIN 86 85 17 71
PAROXETINE HCL 83 72 18 62
METOPROLOL TARTRATE 82 49 19 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 66 20 22
TRAMADOL HCL 79 41 20 15
ZOLPIDEM TARTRATE 79 38 20 21
ENALAPRIL MALEATE 78 51 23 50
TAMSULOSIN HCL 74 63 24 30
BYSTOLIC 74 57 24 165
ENDOCET 71 19 S2 26 227
RANITIDINE HCL 71 35 26 25
CLOPIDOGREL 70 48 28 39
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 61 28 91
SINGULAIR 68 61 30 120
GLYBURIDE 66 51 R 31 83
NEXIUM 65 50 32 53
POTASSIUM CHLORIDE 65 62 32 16
ESCITALOPRAM OXALATE 61 18 34 73
FENTANYL 61 43 S2 34 48
ADVAIR DISKUS 59 39 36 41
CYCLOBENZAPRINE HCL 58 18 R 37 43
ETODOLAC 55 18 38 178
LOVASTATIN 55 33 38 24
DIOVAN 54 52 40 123
DONEPEZIL HCL 52 52 41 28
PLAVIX 51 37 42 75
IPRATROPIUM-ALBUTEROL 50 50 43 136
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.